Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
After finishing at $100.50 in the prior trading day, Jazz Pharmaceuticals plc (NASDAQ: JAZZ) closed at $101.75, up 1.24%. In other words, the price has increased by $1.24 from its previous closing price. On the day, 0.92 million shares were traded.
Ratios:
Our goal is to gain a better understanding of JAZZ by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 2.06 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 4.55. For the most recent quarter (mrq), Quick Ratio is recorded 3.99 and its Current Ratio is at 4.46. In the meantime, Its Debt-to-Equity ratio is 1.51 whereas as Long-Term Debt/Eq ratio is at 1.50.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, UBS on March 07, 2025, Upgraded its rating to Buy and sets its target price to $179 from $145 previously.
Wells Fargo Upgraded its Equal Weight to Overweight on February 13, 2025, whereas the target price for the stock was revised from $130 to $170.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Apr 01 ’25 when COZADD BRUCE C sold 1,500 shares for $123.75 per share. The transaction valued at 185,625 led to the insider holds 440,307 shares of the business.
COZADD BRUCE C bought 2,000 shares of JAZZ for $250,625 on Apr 01 ’25. On Mar 10 ’25, another insider, Iannone Robert, who serves as the EVP, Global Head of R&D & CMO of the company, sold 2,403 shares for $138.41 each. As a result, the insider received 332,605 and left with 79,621 shares of the company.
Valuation Measures:
As of this moment, Jazz’s Price-to-Earnings (P/E) ratio for their current fiscal year is 11.70, and their Forward P/E ratio for the next fiscal year is 4.45. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.29. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.52 while its Price-to-Book (P/B) ratio in mrq is 1.51.
Stock Price History:
Over the past 52 weeks, JAZZ has reached a high of $148.06, while it has fallen to a 52-week low of $95.49. The 50-Day Moving Average of the stock is -21.51%, while the 200-Day Moving Average is calculated to be -14.15%.
Shares Statistics:
A total of 60.63M shares are outstanding, with a floating share count of 57.97M. Insiders hold about 4.54% of the company’s shares, while institutions hold 97.64% stake in the company.
